Termination and transfer of NATUREX liquidity contract
Termination of the liquidity contract concluded with NATIXIS
On 24 June 2013, NATUREX informed NATIXIS of the termination of the contract that complies with the Code of Conduct of the AMAFI recognized by the AMF (French Market Authorities).
The following elements were in the liquidity account as of June 30th, 2013:
- 8 814 NATUREX shares
- 246,196.20 euros
This information was released in July 5th, 2013 as part of the half yearly report of the liquidity contract.
Transfer and implementation of the liquidity contract with EXANE BNP Paribas
From August 13th, 2013 and for a period ending on December 31st, 2013, renewable by tacit agreement, Naturex has appointed Exane BNP Paribas animation of its shares under a liquidity contract in accordance with the AMAFI Charter of ethics recognized by the AMF (French Market Authorities).
The resources provided by this contract were transferred between August 13th and August 16th, 2013 and credited to the liquidity account, namely:
- 7,154 NATUREX shares
- 346,979.52 euros
This information was published on August 30th, 2013 in the interim financial report 2013.
Download our press releases and other publications on www.naturex.com
Naturex has been listed on NYSE Euronext Paris, Compartment B (MidCaps), since October 1996.
 |
Total number of shares comprising the share capital: 7,840,877 ISIN FR0000054694 Naturex is a component of the CAC Small and Gaïa indexes. Naturex is eligible for the "long only" Deferred Settlement Service (SRD). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX's head office is based in Avignon. The company employs more than 1,400 people and benefits from 8 sourcing offices around the world and high-performance manufacturing operations across 15 sites in Europe, in Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
| Contacts | |
|
Thierry Lambert Chairman and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
Thierry Bertrand Lambert Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 [email protected] |
|
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 [email protected] |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 [email protected] |
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-33478-cp-_-naturex-180913.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews
